Salarius Pharmaceuticals has agreed to merge with biopharmaceutical company Decoy Therapeutics.

Salarius Pharmaceuticals (SLRX) and Decoy Therapeutics announce the signing of a definitive agreement under which Decoy Therapeutics will merge ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and therefore flagged by the Incapsula network. Incapsula displays this page for ...

Salarius Pharmaceuticals, Inc. (SLRX), a clinical-stage biopharmaceutical company focused on developing cancer therapies, Monday ...

The newly formed company will be named Decoy Therapeutics. This proposed transaction is expected to facilitate multiple value-creating inflection points with Decoy’s pipeline of peptide ...